MRI-compatible neurostimulator goes to work relieving pain

A 62-year-old Pennsylvania man has become the first in the world to be implanted with a neurotransmitter that both blocks spinal pain and safely stands up to MRI scanning, according to The Intelligencer of Doylestown, Pa.

MRI exams, of course, are key to managing the care of patients with chronic spinal pain.

“All patients with a spinal cord stimulation system should have the ability to be offered the same imaging options as those without one,” says Steven Falowski, MD, chief of functional neurosurgery at St. Luke’s University Health Network in Bethlehem.

Click below for the story, which includes video news coverage:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.